SEPTEMBER 15, 2007
VOLUME 4 NO. 15

ADVANCES in MEDICINE

Arm cuff protects heart during bypass

Cutting off bloodflow to the arm prevents CABG-related cardiac injuries


An old-fashioned blood pressure cuff to the arm protects bypass patients' hearts during surgery. The technique, which induces transient upper limb ischemia, is described by a British team in the August 18 edition of the Lancet.

Coronary artery bypass graft (CABG) is a common but risky procedure, and ischemia and reperfusion injuries incurred during revasculatization have been the focus of intense research. The simple and effective blood pressure cuff approach could soon become a standard part of the heart surgeon's CABG protocol, predicts lead author Dr Derek Hausenloy of London's Hatter Cardiovascular Institute via email.

DAMAGE CONTROL
The researchers tested the effects of three five-minute upper-right arm cuffs inflated to 200mmHG on 27 patients after anesthesia for CABG surgery.

Serum troponin-t levels were measured before and up to 72 hours after surgery, in patients with and controls without the treatment. Indicators of cardiac necrosis, troponins are released from damaged myocytes, and their high levels are associated with adverse outcomes in CABG patients.

A striking difference in troponin-t levels was revealed: levels were 43% lower over a 72-hour period in the patients who'd received the remote ischemic preconditioning (20.58 µg/L versus 36.12 µg/L in the non-preconditioned patients).

While the effect is clear, how the inflator cuff protects against tissue death in the heart remains a mystery. The authors theorize that the interrupted blood flow in the arm somehow signals the heart, by either a hormonal or a neuronal mechanism.

GENTLER APPROACH
The concept of ischemic preconditioning has been around since the mid-80s. In natural experiments, prodromal angina seems to predict better survival and reduced infarct size following MI.

Dr Stephen Fremes, division head of cardiovascular surgery at Sunnybrook in Toronto, has done a lot of work in the field and is impressed by the Lancet study. "There are a number of different strategies to try and improve myocardial protection," says Dr Fremes, "this one preemptively puts the myocardium in a state so it's resistant to injury."

A big factor that makes the blood pressure cuff method so attractive is its non-invasive nature. Dr Fremes says other, more invasive ischemic preconditioning techniques have been attempted experimentally. "In early human studies, there's been ischemic preconditioning with angioplasty balloons, or with cross-clamping of the coronary artery," he says, "but what they've done here is remote conditioning, using another 'organ,' in this case, an arm."

MULTIPLE USES
"There is no reason why remote preconditioning should not also protect cerebral and renal functioning post CABG surgery," says Dr Hausenloy. "In many cases the injury sustained to these organs arises from acute ischemia-reperfusion of them. It could also be used in other surgical settings where ischemia-reperfusion of the organ is sustained such as hepatic or bowel surgery."

Despite the promising results, there's a lot left to be learned about remote ischemic preconditioning. "The study is a green light for another study in less well-defined patients, and to look at harder clinical outcomes in addition to troponin-t, like CKMB levels, and clinical recovery," says Dr Fremes.

That's precisely what Dr Hausenloy's got in mind. Following on from the current study's success, a large multicentre trial has been planned. "If it has a positive effect on clinical outcomes," says Dr Hausenloy, "then there is no reason why this non-invasive procedure should not be adopted for all patients undergoing CABG surgery."

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T. (514) 995-4398